China Universal Asset Management Company’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-8,117
Closed -$477K 458
2023
Q4
$477K Buy
8,117
+6,365
+363% +$374K 0.09% 150
2023
Q3
$76.3K Buy
1,752
+990
+130% +$43.1K 0.02% 211
2023
Q2
$27.5K Sell
762
-24
-3% -$867 0.01% 241
2023
Q1
$29.2K Buy
786
+201
+34% +$7.47K 0.01% 186
2022
Q4
$26.5K Buy
585
+64
+12% +$2.9K 0.01% 160
2022
Q3
$36K Buy
+521
New +$36K 0.02% 131
2022
Q2
Sell
-247
Closed -$20K 99
2022
Q1
$20K Sell
247
-15,853
-98% -$1.28M 0.01% 76
2021
Q4
$2.36M Buy
+16,100
New +$2.36M 0.56% 57